ArticleACS applied materials & interfaces2025
Ultrashort Peptides as Stabilizing Agents for Colloidal Nanogold.
Article in ACS applied materials & interfaces, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Short Peptoid Capping Ligands Stabilize Dispersion of Gold Nanospheres in Aqueous Solutions.Langmuir : the ACS journal of surfaces and colloids · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ultrashort peptides hold immense potential as structural tools for enhancing the colloidal stability of nanomaterials, such as nanogold. However, such applications have been largely unexplored in part due to the inherent complexity in designing, synthesizing, and testing short peptides as colloidal nanoparticle stabilizers. In this work, we use a motif-function-guided process for peptide synthesis and high throughput screening to evaluate the colloidal stability of spherical nanogold solutions and pentapeptides. We have successfully built a library of peptides capable of stabilizing colloidal nanogold at peptide concentrations of ≤1.0 μM. This represents a 50-100-fold reduction in the concentration required for stability compared to other small molecules used as capping agents, which illustrates the potential of using short peptide sequences as colloidal nanogold stabilizers. Our findings could significantly impact the future development of high-affinity surface modifiers for the custom engineering of nanogold by providing a deeper understanding of the complex interactions between nanoparticles and peptides.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.